Liquid Phase Peptide Synthesis Market Outlook:
Liquid Phase Peptide Synthesis Market size was over USD 5.96 billion in 2025 and is projected to reach USD 15.6 billion by 2035, witnessing around 10.1% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of liquid phase peptide synthesis is assessed at USD 6.5 billion.
Growing Demand for peptide-based therapeutics due to their effectiveness in treating various diseases like cancer, metabolic disorders, and hormonal deficiencies fuels the LPPS market. Cancer is one of the leading causes of death globally, Current cancer treatment regimens often cause significant adverse side effects and fall short of effectively eliminating advanced disease. Because of the diverse functions that peptides offer, this nonviral carrier has rapidly gained exposure and popularity as a prospective delivery vehicle. In 2020, there were about 18.1 million cases of cancer worldwide.
Moreover, liquid-phase synthesis was the original method for creating peptides, numerous studies have looked into how to improve solid-phase synthesis in order to decrease costs, increase scalability, and waste less amino acids and solvents. High-volume industrial production uses liquid-phase peptide synthesis, which can produce higher-quality peptides at a cost of more time.
